<DOC>
	<DOCNO>NCT00984477</DOCNO>
	<brief_summary>The purpose study determine quickly AZD5122 absorb clear body give healthy , non smoking male different dose level . This 2 part study , Part B single group subject give oral dose intravenous microdose AZD5122 specialist unit . For part B placebo treatment give .</brief_summary>
	<brief_title>Study Investigate Activity AZD5122 When Given Single Dose Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>Provision sign date , write informed consent . Normal physical examination , laboratory value , blood pressure pulse Healthy male caucasian subject Subjects must history gastrointestinal , hepatic renal disease , condition know interfere drug absorb , use eliminate body . Subjects must abnormal blood urine test hsCRP , circulate neutrophil , haematocrit , haemoglobin renal function Subjects must crystals trace blood urine</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>healthy subject</keyword>
	<keyword>AZD5122</keyword>
	<keyword>single oral dose</keyword>
	<keyword>phase 1</keyword>
	<keyword>Healthy volunteer phase 1 study</keyword>
</DOC>